{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:56:23Z","timestamp":1776660983688,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10620-023-07969-3","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T08:01:43Z","timestamp":1684742503000},"page":"3442-3450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-4692","authenticated-orcid":false,"given":"Alberto E.","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Pollarsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"M\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique G.","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"7969_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.abi5200","volume":"374","author":"R Medzhitov","year":"2021","unstructured":"Medzhitov R. The spectrum of inflammatory responses. Science. 2021;374:1070\u20131075.","journal-title":"Science."},{"key":"7969_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.immuni.2022.03.016","volume":"55","author":"C Nathan","year":"2022","unstructured":"Nathan C. Nonresolving inflammation redux. Immunity. 2022;55:592\u2013605.","journal-title":"Immunity."},{"key":"7969_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi M, Moreau R, Angeli P et al. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63:1272\u20131284.","journal-title":"J Hepatol."},{"key":"7969_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2021","unstructured":"Arroyo V, Angeli P, Moreau R, investigators from the EASL-CLIF Consortium, Grifols Chair and European Foundation for the Study of Chronic Liver Failure (EF-Clif) et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2021;74:670\u2013685.","journal-title":"J Hepatol."},{"key":"7969_CR5","doi-asserted-by":"publisher","first-page":"718896","DOI":"10.3389\/fmed.2021.718896","volume":"23","author":"TM Kronborg","year":"2021","unstructured":"Kronborg TM, Ytting H, Hobolth L et al. Novel anti-inflammatory treatments in cirrhosis. A literature-based study. Front Med (Lausanne). 2021;23:718896.","journal-title":"Front Med (Lausanne)."},{"key":"7969_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89\u2013118.","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"7969_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez R, Caraceni P, Bernardi M et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836\u20131846.","journal-title":"Hepatology."},{"key":"7969_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","volume":"137","author":"G Marsche","year":"2013","unstructured":"Marsche G, Saemann MD, Heinemann A et al. Inflammation alters HDL composition and function: implications for HDL-raising therapies. Pharmacol Ther. 2013;137:341\u2013351.","journal-title":"Pharmacol Ther."},{"key":"7969_CR9","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s10620-020-06630-7","volume":"66","author":"AE Mu\u00f1oz","year":"2021","unstructured":"Mu\u00f1oz AE, Pollarsky F, Marino M et al. Safety of chronic simvastatin treatment in patients with decompensated cirrhosis: many adverse events but no liver injury. Dig Dis Sci. 2021;66:3199\u20133208. https:\/\/doi.org\/10.1007\/s10620-020-06630-7.","journal-title":"Dig Dis Sci."},{"key":"7969_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg. 1973;60:646\u2013649.","journal-title":"Brit J Surg."},{"key":"7969_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/hep.23478","volume":"51","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Friedman S, Iredale J et al. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445\u20131449.","journal-title":"Hepatology."},{"key":"7969_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","volume":"150","author":"JG Abraldes","year":"2016","unstructured":"Abraldes JG, Villanueva C, Aracil C et al. Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis. Gastroenterology. 2016;150:1160-1170.e3.","journal-title":"Gastroenterology."},{"key":"7969_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2468-1253(19)30320-6","volume":"5","author":"E Pose","year":"2020","unstructured":"Pose E, Napoleone L, Amin A et al. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol. 2020;5:31\u201341.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7969_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2165\/00002018-200528060-00005","volume":"28","author":"F Delco","year":"2005","unstructured":"Delco F, Tchambaz L, Schlienger R et al. Dose adjustment in patients with liver disease. Drug Saf. 2005;28:529\u2013545.","journal-title":"Drug Saf."},{"key":"7969_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/jlts.2002.31340","volume":"8","author":"RS Brown Jr","year":"2002","unstructured":"Brown RS Jr, Kumar KS, Russo MW et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl. 2002;8:278\u2013284.","journal-title":"Liver Transpl."},{"key":"7969_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","volume":"75","author":"JP Arab","year":"2021","unstructured":"Arab JP, D\u00edaz LA, Baeza N et al. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol. 2021;75:1026\u20131033.","journal-title":"J Hepatol."},{"key":"7969_CR17","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s11739-012-0802-0","volume":"7","author":"A Gatta","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7:S193\u2013S199.","journal-title":"Intern Emerg Med."},{"key":"7969_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.1840180211","volume":"18","author":"PE Ballmer","year":"1993","unstructured":"Ballmer PE, Walshe D, McNurlan MA et al. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatology. 1993;18:292\u2013297.","journal-title":"Hepatology."},{"key":"7969_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/00365517709091486","volume":"37","author":"HH Parving","year":"1977","unstructured":"Parving HH, Jensen HA, Westrup M. Increased transcapillary escape rate of albumin and IgG in essential hypertension. Scand J Clin Lab Invest. 1977;37:223\u2013227.","journal-title":"Scand J Clin Lab Invest."},{"key":"7969_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151\u20131157.","journal-title":"Hepatology."},{"key":"7969_CR21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jhep.2014.06.034","volume":"61","author":"JG Orr","year":"2014","unstructured":"Orr JG, Homer T, Ternent L et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61:1158\u20131165.","journal-title":"J Hepatol."},{"key":"7969_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejim.2019.09.004","volume":"70","author":"C Labenz","year":"2019","unstructured":"Labenz C, Toegens G, Schattenberg JM et al. Health-related quality of life in patients with compensated and decompensated liver cirrhosis. Eur J Intern Med. 2019;70:54\u201359.","journal-title":"Eur J Intern Med."},{"key":"7969_CR23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","volume":"57","author":"E Sola","year":"2012","unstructured":"Sola E, Watson H, Graupera I et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57:1199\u20131206.","journal-title":"J Hepatol."},{"key":"7969_CR24","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1478-3231.2011.02598.x","volume":"31","author":"F Moscucci","year":"2011","unstructured":"Moscucci F, Nardelli S, Pentassuglio I et al. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int. 2011;31:1505\u20131510.","journal-title":"Liver Int."},{"key":"7969_CR25","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/j.1572-0241.2001.03956.x","volume":"96","author":"ZM Younossi","year":"2001","unstructured":"Younossi ZM, Boparai N, Price LL et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199\u20132205.","journal-title":"Am J Gastroenterol."},{"key":"7969_CR26","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1080\/00365520600825117","volume":"41","author":"E Kalaitzakis","year":"2006","unstructured":"Kalaitzakis E, Simren M, Olsson R et al. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol. 2006;41:1464\u20131472.","journal-title":"Scand J Gastroenterol."},{"key":"7969_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11901-016-0287-9","volume":"15","author":"L Cabrera","year":"2016","unstructured":"Cabrera L, Abraldes JG. Statins: the panacea of cirrhosis? Curr Hepatology Rep. 2016;15:1\u20137.","journal-title":"Curr Hepatology Rep."},{"key":"7969_CR28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.10.007","volume":"150","author":"A Mohanty","year":"2016","unstructured":"Mohanty A, Tate JP, Garcia-Tsao G. Statins are associated with decreased risk of decompensation and death in veterans with hepatitis C-related compensated cirrhosis. Gastroenterology. 2016;150:e1.","journal-title":"Gastroenterology."},{"key":"7969_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/apt.14243","volume":"46","author":"UC Bang","year":"2017","unstructured":"Bang UC, Benfield T, Bendtsen F. Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study. Aliment Pharmacol Ther. 2017;46:673\u2013680.","journal-title":"Aliment Pharmacol Ther."},{"key":"7969_CR30","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.jacc.2013.08.1626","volume":"62","author":"MJ Blaha","year":"2013","unstructured":"Blaha MJ, Martin SS. How do statins work? Changing paradigms with implications for statin allocation. J Am Coll Cardiol. 2013;62:2392\u20132394.","journal-title":"J Am Coll Cardiol."},{"key":"7969_CR31","doi-asserted-by":"publisher","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","volume":"296","author":"M Moreno","year":"2009","unstructured":"Moreno M, Ramalho LN, Sancho-Bru P et al. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. Am J Physiol Gastrointest Liver Physiol. 2009;296:G147\u2013G156.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"7969_CR32","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep.26127","volume":"57","author":"V La Mura","year":"2013","unstructured":"La Mura V, Pasarin M, Meireles CZ et al. Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction. Hepatology. 2013;57:1172\u20131181.","journal-title":"Hepatology."},{"key":"7969_CR33","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FAH et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195\u20132207.","journal-title":"N Engl J Med."},{"key":"7969_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijid.2021.08.004","volume":"110","author":"C Diaz-Arocutipa","year":"2021","unstructured":"Diaz-Arocutipa C, Melgar-Talavera B et al. Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients. Int J Infect Dis. 2021;110:374\u2013381.","journal-title":"Int J Infect Dis."},{"key":"7969_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2021","unstructured":"Costa D, Simbrunner B, Jachs M et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2021;74:819\u2013828.","journal-title":"J Hepatol."},{"key":"7969_CR36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, Fernandez J, Papp M, PREDICT STUDY group of the EASL-CLIF Consortium et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73:842\u2013854.","journal-title":"J Hepatol."},{"key":"7969_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani A, Garlanda C. Humoral innate immunity and acute-phase proteins. N Engl J Med. 2023;388:439\u2013452.","journal-title":"N Engl J Med."},{"key":"7969_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.22913","volume":"50","author":"R Jalan","year":"2009","unstructured":"Jalan R, Schnurr K, Mookerjee RP et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50:555\u2013564.","journal-title":"Hepatology."},{"key":"7969_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.22582","volume":"49","author":"A Galbois","year":"2009","unstructured":"Galbois A, Thabut D, Tazi KA et al. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology. 2009;49:175\u2013184.","journal-title":"Hepatology."},{"key":"7969_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jhep.2020.08.009","volume":"74","author":"E Sola","year":"2021","unstructured":"Sola E, Pose E, Campion D, for the LiverHope Consortium Investigators et al. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol. 2021;74:200\u2013219.","journal-title":"J Hepatol."},{"key":"7969_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","volume":"104","author":"C Verrill","year":"2009","unstructured":"Verrill C, Markham H, Templeton A et al. Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 2009;104:768\u2013774.","journal-title":"Addiction."},{"key":"7969_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-0038-1676805","volume":"39","author":"B Kok","year":"2019","unstructured":"Kok B, Abraldes JG. Child-Pugh classification: Time to abandon? Semin Liver Dis. 2019;39:96\u2013103.","journal-title":"Semin Liver Dis."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-07969-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T04:07:51Z","timestamp":1689653271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-07969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["7969"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-07969-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"30 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. Granted Scholarships: Florencia Pollarsky was awared by the \"Estudio de Seguridad, Sobrevida y Calidad de Vida en Pacientes con Cirrosis Descompensada que Reciben Tratamiento Convencional m\u00e1s Simvastatina.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}